AIG vs EBS
American International Group Inc (AIG) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AIG and EBS stock pages for the full models.
Not investment advice.